Beremagene-Geperpavec-Svdt - Uses, Dosage, Precautions, Side Effects, and Pharmacological Aspects
Beremagene-geperpavec-svdt is a gene therapy for epidermolysis bullosa that targets COL7A1 gene mutations, promoting wound healing and skin integrity.
Dystrophic Epidermolysis Bullosa - Symptoms, Diagnosis, and Treatment
A genetic skin condition called dystrophic epidermolysis bullosa manifests at birth and primarily affects the skin and nails. Read the article to know more.
